Equity Overview
Price & Market Data
Price: $0.668
Daily Change: +$0.027 / 4.04%
Daily Range: $0.61 - $0.669
Market Cap: $10,091,850
Daily Volume: 5,756
Performance Metrics
1 Week: 23.27%
1 Month: -11.83%
3 Months: -89.33%
6 Months: -79.97%
1 Year: -64.59%
YTD: -90.27%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.